Clot breakdown in cancer patients with bleeding problems
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how bleeding problems in patients with cancer affect the body's ability to break down blood clots. Researchers hope to find better ways to manage and treat these complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You are currently in a hospital unit such as emergency, intensive care, or a hematology/oncology service.
- You have a blood clotting problem: low platelets (under 100) and an INR above 1.2 (a measure of bleeding risk).
- You either have a fast-growing blood cancer (like leukemia or lymphoma), or a solid tumor (like prostate, pancreatic, bile duct, or advanced digestive tract cancer), or you are having complex liver/biliary surgery.
- You are not currently bleeding, not taking blood thinners, and do not have cirrhosis.
- You weigh at least 50 kg (about 110 lbs) and are not pregnant.
- For the control group, you have septic shock (a severe infection causing organ failure) but no cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Hear when a new Disseminated Intravascular Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.